Shares of Max Healthcare Institute experienced a decline of over 6 percent on Friday following the hospital chain’s announcement of a modest increase in its fourth-quarter profits. Investors expressed concerns about margin pressures despite the company’s consistent operational growth and ongoing expansion initiatives.
Leading the Nifty 50 index in losses, the stock closed at ₹1,023.25, down 6.22 percent, after reaching an intraday low of ₹1,011, compared to its previous close of ₹1,091.10.
For the quarter ending March 31, 2026, Max Healthcare reported a consolidated profit after tax of ₹387 crore, reflecting a 3 percent year-on-year increase from ₹376 crore during the same quarter last year. Gross revenue for the quarter rose by 10 percent to ₹2,664 crore year-on-year.
Operationally, the company maintained stable metrics, reporting a bed occupancy rate of 75 percent, with occupied bed days increasing by 8 percent year-on-year. The average revenue per occupied bed in Q4 FY26 was ₹77,900, slightly higher than ₹77,100 in the preceding year, indicating marginal improvement.
For the fiscal year 2026, the company recorded network gross revenue of ₹10,538 crore, and profit after tax, after accounting for exceptional items, rose by 22 percent year-on-year to ₹1,631 crore, up from ₹1,336 crore in FY25.
The board of Max Healthcare recommended a final dividend of ₹2 per equity share for FY26, alongside the approval of a ₹1,400 crore investment for a new 712-bed greenfield hospital at Shaheed Path in Lucknow. This facility, set to span five acres, is anticipated to be operational by FY30 and will serve as the company’s second hospital in the city.
